Co-exposure to lead increases the renal response to low levels of cadmium in metallurgy workers  by Hambach, R. et al.
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 i  g  h  l  i  g  h  t  s
We  performed  a  cross-sectional  survey  in  122  metallurgic  reﬁnery  workers.
We  assessed  the  effect  of co-exposure  to Cd  and  Pb on early  renal  biomarkers.
The  exposure  to  Cd and  Pb  was  low  to  moderately  high,  respectively.
Pb  increases  the  strength  of  the association  between  Cd and  renal  biomarkers.
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Purpose:  Research  on the  effect  of  co-exposure  to Cd  and Pb  on  the kidney  is scarce.  The  objective  of  the
present  study  was  to assess  the  effect  of  co-exposure  to  these  metals  on  biomarkers  of  early  renal  effect.
Methods: Cd  in blood  (Cd-B),  Cd in urine  (Cd-U),  Pb  in blood  (Pb-B)  and  urinary  renal  biomarkers,
i.e., microalbumin  (-Alb),  beta-2-microglobulin  (2-MG),  retinol  binding  protein  (RBP),  N-acetyl--d-
glucosaminidase  (NAG),  intestinal  alkaline  phosphatase  (IAP)  were  measured  in 122  metallurgic  reﬁnery
workers  examined  in  a cross-sectional  survey.
Results and  conclusions:  The  median  Cd-B,  Cd-U, Pb-B  were:  0.8  g/l (IQR  = 0.5,  1.2),  0.5  g/g creatinineenal
iomarkers
admium
ead
(IQR  = 0.3,  0.8)  and  158.5  g/l (IQR  =  111.0,  219.3),  respectively.  The  impact  of  Cd-B  on  the urinary  excre-
tion  of  NAG  and  IAP  was  only  evident  among  workers  with  Pb-B  concentrations  ≥75th  percentile.  The
association  between  Cd-U  and  the  renal  markers  NAG  and  RBP  was  also  evidenced  when  Pb-B  ≥75th
percentile.  No  statistically  signiﬁcant  interaction  terms  were  observed  for the  associations  between  Cd-B
or Cd-U  and  the  other  renal  markers  under  study  (i.e., -Alb  and  2-MG).  Our  ﬁndings  indicate  that  Pb
increases  the  impact  of Cd  exposure  on  early  renal  biomarkers.
 2013©
. IntroductionCadmium (Cd) and lead (Pb) are widespread occupational and
nvironmental toxicants. Inhalation and ingestion are the two  main
outes of exposure to Cd and Pb (Johri et al., 2010), inhalation being
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the primary route of occupational exposure. After absorption, Cd is
transported in the blood by albumin to the liver where it bounds
to metallothionein (MT). The Cd-MT complex is then released back
into the circulation. This complex of low molecular weight is freely
ﬁltered through the glomerulus and reabsorbed by the proximal
tubule (PT) (Johri et al., 2010; Nordberg, 2009; Sabath and Robles-
Osorio, 2012). Cd up-regulates the MT  production in the liver and
kidney to limit the toxicity of unbound Cd. The kidney is the primary
target of toxicity with respect to chronic exposure to Cd (Johri et al.,
2010). When the renal capacity to produce MT  is overwhelmed,
Open access under CC BY license.renal tubular dysfunction may  occur, as reﬂected by an increased
urinary excretion of low-molecular-weight (LMW)  proteins e.g.,
beta-2-microglobulin (2-MG) and retinol binding protein (RBP),
and renal proximal tubular damage characterized by an excretion
 license.
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f urinary enzymes, e.g., N-acetyl--d-glucosaminidase (NAG) and
rinary intestinal alkaline phosphatase (IAP) (Chaumont et al.,
011; Järup, 2002; Kido et al., 1995; Roels et al., 1999). The exact
ellular processes underlying Cd nephrotoxicity are incompletely
nderstood. Growing attention is going towards the oxidative sta-
us of cells and the production of reactive oxygen species (ROS),
hich is considered to play an import role in Cd-induced toxicity
Devi et al., 2007; Garc¸ on et al., 2007; Hambach et al., 2013a; Johri
t al., 2010; Thijssen et al., 2007; Wieloch et al., 2012). The renal
andling of Pb is much less understood (Chaumont et al., 2012;
onick, 2011; Sabath and Robles-Osorio, 2012). In the circulation,
ost Pb binds to proteins in erythrocytes and is distributed to soft
issues (e.g. kidneys) and bone, the latter being the main depot for
his metal. Pb is bound to low molecular weight proteins (<1% of the
otal) and ﬁltered freely through the glomerulus and reabsorbed
y PT (Sabath and Robles-Osorio, 2012). According to Chaumont
t al. (2012) it is likely that Pb is reabsorbed by the PT as a com-
lex of low molecular weight, similar to the Cd-MT complex. In the
T cells, Pb can cause mitochondrial damage, production of ROS,
ntracellular depletion of gluthatione and apoptosis (Sabath and
obles-Osorio, 2012). Pb exposure affects the glomerular function
e.g., renal hyperﬁltration) (de Burbure et al., 2006; Roels et al.,
994; Weaver et al., 2003), yet, renal tubular effects induced by Pb
xposure are also reported by several authors (Chia et al., 1994;
idlow, 2004; Navas-Acien et al., 2009; Staessen et al., 1992).
High exposure to Cd and Pb rarely occurs in most industrial-
zed countries, but chronic low exposure to these metals is still
 major public health issue (Wang and Fowler, 2008). Recent
esearch suggests adverse renal effects in adults at low level of Cd
nd Pb exposure i.e., Cd in urine (Cd-U) < 2.0 g/g creatinine and
b in blood (Pb-B) < 10 g/l (Ekong et al., 2006; Fadrowski et al.,
010; Fowler, 2009; Hambach et al., 2013a; Weaver et al., 2010,
009). Furthermore, several epidemiological studies have under-
ined that isolated environmental or occupational exposure to Cd
arely occurs and is often associated with Pb exposure (Ekong
t al., 2006; Johri et al., 2010; Roels et al., 1995; Wang and Fowler,
008). However, as reviewed by Choudhury and Mudipalli (2008),
esearch on the effect of combined exposure to Cd and Pb on the
idney in humans is scarce. Cd and Pb can interact with each other
n a complex way  (Johri et al., 2010). Following Wang and Fowler
2008), co-exposure to Cd and Pb may  induce additive or syner-
istic interactions or even new effects that are not observed for
ingle element exposure. Similarities in kidney target areas and
echanisms of toxicity (e.g., inhibition of sulfhydryl group con-
aining enzymes and increased production of ROS) raise concerns
egarding the possible nephrotoxicity of combined exposure to Cd
nd Pb (Navas-Acien et al., 2009).
The aims of this study were: (1) to measure indicators for Cd and
b exposure in workers from a metallurgic reﬁnery company; (2)
o assess early biomarkers of subclinical renal effect (i.e., 2-MG,
-Alb, RBP, NAG, IAP) in those workers; (3) to examine whether
b exposure modiﬁes (i.e., increases or decreases) the effect of Cd
xposure on these biomarkers.
. Material and methods
The study was designed as a cross-sectional survey. Data collection was  per-
ormed by questionnaire and blood and urine were sampled. Approval of the study
rotocol was  obtained from the Medical Ethics Committee of the University of
ntwerp. All participants signed a written informed consent form.
.1. Study populationA total of 122 male workers from a metallurgic reﬁnery company in Belgium par-
icipated in this study. Selection criteria were blue collar workers, co-exposure to Cd
nd  Pb (based on the occupational medical ﬁles), a seniority of minimum one year
nd  voluntary participation. All subjects ﬁlled in a questionnaire on demographictters 222 (2013) 233– 238
characteristics, intake of medication, smoking habits, comorbidity (i.e., hyperten-
sion, diabetes, renal and/or urological problems) and working conditions.
2.2. Analytical methods
2.2.1. Collection of samples
Blood (venipuncture) and spot urine were collected for each subject (n = 122)
during the annual occupational medicine examination. The samples were collected
between January and December 2010 during the working hours between 9.00 a.m.
and 4.00 p.m. They were immediately aliquoted and transferred to appropriate
recipients, stored in a refrigerator (4–8 ◦C) and transported within a half day to the
laboratory where they were stored at either 4 ◦C (Cd-B, Cd-U and Pb-B) or −80 ◦C
(renal markers) till analysis. Samples that were too diluted (creatinine < 30 mg/dl)
or  too concentrated (creatinine > 300 mg/dl) were discarded (Barr et al., 2005;
Lauwerys and Hoet, 1993; WHO, 1996).
2.2.2. Determination of cadmium and lead concentrations
Cd-B (whole blood), Cd-U and Pb-B (whole blood) were measured by elec-
trothermal atomic absorption spectrometry with Zeeman background correction
using a SIMAA 6000 apparatus (Perkin-Elmer) after a 1 + 4 dilution in a Triton X-
100–HNO3–NH4H2PO4 matrix modiﬁer solution. Concentrations were measured
against an addition-calibration curve. Instrumental conditions were set according to
methods published previously. The variability of the methods was <5% whilst detec-
tion  limits in both blood and urine were 0.1 g/l for Cd and 1 g/l for Pb (D’Haese
et  al., 1991).
2.2.3. Determination of renal markers concentrations in urine
Urinary IAP (a brush border enzyme of the S3 tubular segment) was  determined
using an in-house developed enzyme-antigen immunoassay (EAIA) (detection limit:
0.02 U/l) (Verpooten et al., 1992) whilst for total NAG (a proximal tubule lysosomal
enzyme) a colorimetric assay (Roche) (detection limit: 0.1 U/l) and for RBP (a marker
of  proximal tubule dysfunction) a latex immuno assay (detection limit: 5 g/L) were
applied (Bernard and Lauwerys, 1983). For 2-MG (a marker of proximal tubule
dysfunction) measurement we used a particle-enhanced immunonephelometric
method (Dade Behring) (detection limit: 0.02 mg/L) and an immunonephelomet-
ric method for the measurement of -Alb (a marker of glomerular damage) (Dade
Behring) (detection limit: 2.4 mg/l). The urinary creatinine concentration was deter-
mined by means of the Jaffé method.
2.3. Statistical analysis
Samples below the levels of detection (LOD) were attributed a value of half
LOD  for statistical calculations (Glass and Gray, 2001). Continuous dependent vari-
ables were tested for normality by Kolmogorov–Smirnov testing. Concentrations
of  metals and renal markers are expressed as median and interquartile range (25th
percentile, 75th percentile). Non-symmetrically distributed dependent variables are
log-transformed. In order to operationalize the variable Pb-B, we ﬁrst categorized
Pb-B based on quartiles. After that we studied the associations between Cd-B/Cd-
U  and renal markers in the four quartiles of Pb-B (see also Section 3) in order to
identify a threshold value for dichotomization. Then we operationalize Pb-B in an
indicator variable that is equal to one for Pb-B concentrations ≥ threshold and zero
for  Pb-B concentrations < threshold. In order to explore the effect of Pb-B on the
association between Cd (in blood and urine) and renal markers (i.e., modiﬁcation or
interaction), we  performed a multiple linear regression analysis (adjusting for age
and pack-years of smoking) including an interaction term Pb × Cd. We also consid-
ered the presence of modiﬁcation by different parameters (i.e., ever smoking and
analgesic/NSAID use) by including a second interaction term Pb × Cd × smokingever.
All  variables were entered simultaneously into the model. All tests were two-sided;
p-values ≤ 0.05 were considered statistically signiﬁcant; p-values between 0.05 and
0.10  were considered borderline statistically signiﬁcant. Statistical analyses were
performed using IBM SPSS for Windows (version 20).
3. Results
The characteristics of the study population are described in
Table 1.
Table 2 presents the concentrations of Cd, Pb and renal mark-
ers. The median Cd-B and Cd-U were relatively low and below
the Biological Exposure Index (BEI) of the American Conference of
Governmental Industrial Hygienists (ACGIH), <5 g/l and <5 g/g
creatinine, respectively (ACGIH, 2011). The median Pb-B concentra-
tion was moderately high, with 6.7% of the workers showing Pb-B
concentrations above the 300 g/l (BEI-ACGIH) (ACGIH, 2011). The
normal values for 2-MG (<300 g/g creatinine), -Alb (<20 mg/g
creatinine) and NAG (<5.0 U/g creatinine) were exceeded in 3.3%,
4.1% and 1.6% of the samples, respectively, but none of the workers
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Table  1
Study population characteristics.
Number of subjects 122
Age (years) 44.0 (38.0, 49.0)
Seniority (years) 22.0 (7.0, 26.5)
Smoking status
Never-smokers 50 (0.0)
Ex-smokersa 29 (23.8); 11.5 [6.3, 17.6]
Current-smokersa 43 (35.2); 18.0 [9.1, 28.5]
Renal and/or urological problems 8 (6.6)
Hypertension 12 (9.8)
Diabetes 1 (0.8)
Ever analgesic use (>4 weeks) 4 (3.3)
Ever NSAID use (>4 weeks) 8 (6.6)
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Copulation characteristics are expressed as numbers (%) and as amedian (interquar-
ile range) pack years of smoking.
ad a RBP concentration above the normal value (<300 g/g creati-
ine) (Aitio et al., 2007). Out of the 122 workers under study, 12.2%
ad an IAP concentration exceeding the normal value (<2.0 U/g cre-
tinine) (Nuyts et al., 1992).
In order to explore the effect of Pb-B on the association between
d (blood and urine) and renal markers, we ﬁrst categorized
he continuous variable Pb-B in quartiles: below 25th percentile
111.0 g/l), between 25th and 50th percentile (111.0 g/l and
58.5 g/l), between 50th and 75th percentile (158.5 g/l and
19.3 g/l) and above 75th percentile (219.3 g/l). The associations
etween Cd (blood and urine) and renal markers were assessed by
sing multiple linear regression analysis adjusting for age and pack-
ears of smoking. We  compared the regression coefﬁcients (slopes)
etween Cd (blood and urine) and renal markers for the four quar-
iles of Pb-B. Striking differences in the regression coefﬁcients were
een between the highest quartile of Pb-B and the three lower quar-
iles (i.e., very small or even negative slope) (data not shown). These
esults suggest a threshold ≥75th percentile (≥219.3 g/l).
Tables 3 and 4 show the association between Cd (in blood and
rine) and renal markers after adjusting for age and pack-years
f smoking. Five individuals had missing scores on the variable
ack-years of smoking. The statistically signiﬁcant interaction term
b-B × Cd-B indicates that the impact of Cd-B on the enzymes NAG
nd IAP was only evident among workers with Pb-B concentra-
ions ≥75th percentile. The association between Cd-U and the renal
able 2
etals and renal markers (n = 122).
LOD (%)a
Metals
Cd-B (g/l)
Total population 0.8 [0.5, 1.2] 0
Never-smokers 0.6 [0.4, 0.8]
Ex-smokers 0.7 [0.6, 0.9]
Current-smokers 1.3 [1.0, 1.9]
Cd-U (g/g creatinine)
Total population 0.5 [0.3, 0.8] 0
Never-smokers 0.4 [0.3, 0.7]
Ex-smokers 0.6 [0.3, 1.1]
Current-smokers 0.5 [0.3, 1.1]
Pb-B (g/l)
Total population 158.5 [111.0, 219.3] 0
Never-smokers 153.0 [108.0, 211.3]
Ex-smokers 171.0 [109.5, 247.5]
Current-smokers 176.0 [115,229.0]
Renal markers
NAG (U/g creatinine) 1.4 [0.9, 1.9] 0
IAP (U/g creatinine) 0.6 [0.4, 1.0] 0
-Alb (mg/g creatinine) 5.4 [3.3, 8.5] 16
2-MG (mg/g creatinine) 0.1 [0.04, 0.10] 0
RBP (g/g creatinine) 15.9 [7.61, 34.0] 0
oncentrations are expressed as median (interquartile range).
a LOD (%): percentage of values below the detection limit.tters 222 (2013) 233– 238 235
markers NAG and RBP was also evidenced when Pb-B ≥ 75th per-
centile. The interaction term between Pb-B and Cd-U on RBP was  of
borderline statistical signiﬁcance. No statistically signiﬁcant inter-
action terms were observed for the associations between Cd-B and
Cd-U and the other renal markers under study (i.e., -Alb and 2-
MG). Analgesic and NSAID use can have a detrimental effect on the
kidney (Elseviers and De Broe, 1998). After exclusion of workers
with analgesic and NSAID use (>4 weeks), the interaction terms
Pb-B × Cd-B and Pb-B × Cd-U remained statistically signiﬁcant. We
also considered the presence of modiﬁcation by smoking. We  only
found modiﬁcation on the association between Cd-U and NAG. After
exclusion of all ‘ever smokers’ (n = 50), the interaction terms Pb-
B × Cd-B and Pb-B × Cd-U remained statistically signiﬁcant (data
not shown).
4. Discussion
Workers in this study had a relatively low exposure to cad-
mium as reﬂected by Cd-B and Cd-U. Pb-B in our study population
was moderately high. Multiple linear regression analysis adjus-
ting for age and pack-years of smoking showed that Pb-B modiﬁes
the association between Cd-B and NAG/IAP and between Cd-U and
NAG/RBP. Following Nordberg (2010), Cd-B is an indicator of recent
exposure although, upon long-term exposure (i.e., decades), Cd-B
is also reﬂecting body burden. Cd-U is considered a good biomarker
of body burden (Nordberg, 2010). Pb-B is the most commonly used
marker of Pb exposure and ‘reﬂects a combination of exposure dur-
ing the last month and several years back in time’ (Skerfving and
Bergdahl, 2007).
Several studies have illustrated the effect of co-exposure to Cd
and Pb on the kidney. For example, Cárdenas et al. (1993) conducted
a study among 82 workers recruited from a Pb smelter. Workers
with a Pb-B concentration above 250 g/l and a duration of expo-
sure of at least one year, were included in the ‘Pb exposed group’. Pb
exposed workers (n = 41; mean Pb-B = 480.0 g/l; Cd-U = 0.9 g/g
creatinine) had a statistically signiﬁcant higher concentration
of NAG as compared with control workers (n = 41; mean Pb-
B = 167.0 g/l; mean Cd-U = 0.4 g/g creatinine): 1.6 U/g creatinine
(range: 0.82–5.21) versus 1.2 U/g creatinine (range: 0.49–2.93),
respectively. The prevalence of abnormal NAG values (cutoff
value > 2.21) in the whole population was not correlated with Pb-B.
Albeit, Cárdenas et al. (1993) found a positive association between
Cd-U and NAG (B = 0.20; r = 0.39; p < 0.001). The authors mentioned
that the increase in NAG concentration might be induced by a com-
bined effect of Cd and Pb (Cárdenas et al., 1993). Similar results
are reported by Roels et al. (1994). These researchers performed a
study among 144 lead smelter workers with concomitant exposure
to Cd and Pb. Exposed workers had to be ‘occupationally exposed
to Pb for at least ﬁve years and their historical Pb-B should have
regularly exceeded 300 g/l’. Pb exposed subjects (n = 76) not only
had a statistically signiﬁcant higher Pb-B (430 g/l versus 141 g/l)
but also their Cd-B and Cd-U levels (1.2 g/l and 1.0 g/g cre-
atinine, respectively) were increased as compared with control
subjects (0.6 g/l and 0.53 g/g creatinine, respectively). Multiple
linear regression analyses on the total population showed that Cd-U
was the only variable that was statistically signiﬁcantly associated
with NAG. Furthermore, similar correlation coefﬁcients between
Cd-U and NAG were found for the exposed group (slope = 0.40;
r = 0.35; p < 0.001) and the control group (slope = 0.33; r = 0.41;
p < 0.005). This made the authors conclude that the increased NAG
concentration in the Pb exposed group might have been caused
by their concomitant exposure to Cd (Roels et al., 1994). These
ﬁndings correspond well with our results, albeit both Pb and Cd
concentrations in our study population were signiﬁcantly lower.
Garc¸ on and co-workers (2004) assessed the effect of co-exposure
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Table 3
Effect of Pb-B on the associations between Cd-B and renal markers after adjustment for confounders.
Independent variables Dependent variables
Ln NAG (n = 117)
Mean = 0.33; S.D. = 0.57
Ln IAP (n = 117)
Mean = −0.53; S.D. = 0.94
Ln -Alb (n = 117)
Mean = 1.70; S.D. = 0.82
Ln 2-MG (n = 177)
Mean = −2.74; S.D. = 0.78
B S.E. p R2 B S.E. p R2 B S.E. p R2 B S.E. p R2
0.13a 0.14a 0.05 0.02
Cd-B  −0.09 0.12 0.46 −0.38 0.20 0.07b −0.09 0.18 0.62 −0.10 0.18 0.59
Pb-Bc −0.33 0.22 0.13 −0.71 0.36 0.05a −0.26 0.33 0.43 −0.43 0.32 0.18
Pb-B  × Cd-B 0.39 0.17 0.02a 0.73 0.27 0.01a 0.33 0.25 0.19 0.17 0.24 0.47
Independent variables Dependent variables
Ln RBP (n = 117)
Mean = 2.74; S.D. = 1.08
B S.E. p R2
0.14a
Cd-B 0.34 0.23 0.15
Pb-Bc −0.70 0.42 0.10
Pb-B  × Cd-B 0.17 0.31 0.59
Multiple linear regression analysis after adjustment for age and pack-years of smoking. Regression coefﬁcients (B) with standard error (S.E.). Skewed distributed data are
log-transformed.
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la Signiﬁcance level: p ≤ 0.05.
b p-Values between 0.05 and 0.10 are considered borderline statistically signiﬁca
c Pb-B ≥ 75th percentile = 1/Pb-B < 75th percentile = 0.
o Pb and Cd on renal markers among 35 male workers from a
on-ferrous smelter. The mean exposure levels were moderate
Pb-B = 395.7 g/l; Pb-U = 95.2 g/g creatinine; Cd-B = 5.8 g/l and
d-U = 4.7 g/g creatinine). Simple correlation analyses showed
 statistically signiﬁcant correlation (r = 0.36; p < 0.01) between
b-U and alpha glutathione S-transferases (-GST, a marker of
roximal tubule damage). Multiple correlation analysis revealed
 statistical signiﬁcant correlation (r = 0.45; p < 0.05) between -
ST and Pb-U and Cd-U (Garc¸ on et al., 2004). The same research
roup performed a study among 57 workers recruited from a non-
errous smelter exposed to Cd and Pb. The mean Cd-B and Cd-U
ere 3.3 g/l and 2.5 g/g creatinine, respectively whilst the mean
b-B and Pb-U levels were moderately increased (387.1 g/l and
17.7 g/g creatinine, respectively). Two way analyses of variance
able 4
ffect of Pb-B on the associations between Cd-U and renal markers after adjustment for c
Independent variables Dependent variables
Ln NAG (n = 117)
Mean = 0.33; S.D. = 0.57
Ln IAP (n = 117)
Mean = −0.53; S.D. = 0.94
B S.E. p R2 B S.E. p 
0.18a
Cd-U  −0.11 0.15 0.44 −0.06 0.26 0.81 
Pb-B  −0.56 0.22 0.01a −0.39 0.37 0.31 
Pb-B  × Cd-Uc 0.84 0.24 0.001a 0.56 0.41 0.17 
Independent variables Dependent variables
Ln RBP (n = 117)
Mean = 2.74; S.D. = 1.08
B S.E
Cd-U 0.01 0.2
Pb-B  −1.07 0.4
Pb-B × Cd-Uc 0.85 0.4
ultiple linear regression analysis after adjustment for age and pack-years of smoking. 
og-transformed.
a Signiﬁcance level: p ≤ 0.05.
b p-Values between 0.05 and 0.10 are considered borderline statistically signiﬁcant.
c Pb-B ≥ 75th percentile = 1/Pb-B < 75th percentile = 0.(ANOVA) illustrated that variations in -GST were mainly inﬂu-
enced by Pb exposure alone (Garc¸ on et al., 2007). Navas-Acien
et al. (2009) conducted an environmental study among 14.778
adults aged >20 years. The geometric mean levels of Cd-B and Pb-
B were 0.41 g/l and 15.8 g/l, respectively. The authors found
that coexposure to Cd and Pb was  a strong determinant of renal
dysfunction with a 4-fold increased odds of having both albumin-
uria (i.e., ≥30 mg/g creatinine) and reduced glomerular ﬁltration
rate (GFR) (<60 ml/min/1.73 m2) when comparing participants of
the three highest quartiles with participants of the lowest quartile
(Navas-Acien et al., 2009).Our data revealed that the association between Cd-U and RBP
was inﬂuenced by the concomitant exposure to Cd and Pb. How-
ever, the association was of borderline statistical signiﬁcance. No
onfounders.
Ln -Alb (n = 117)
Mean = 1.70; S.D. = 0.82
Ln 2-MG (n = 177)
Mean = −2.74; S.D. = 0.78
R2 B S.E. p R2 B S.E. p R2
0.11a 0.07 0.04
0.38 0.23 0.10 0.27 0.22 0.22
0.02 0.33 0.96 −0.31 0.32 0.34
−0.001 0.36 0.99 −0.02 0.35 0.97
. p R2
0.13a
9 0.97
3 0.01a
7 0.07b
Regression coefﬁcients (B) with standard error (S.E.). Skewed distributed data are
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tatistically signiﬁcant interaction terms were observed for the
ssociations between B2-MG and Cd-B and Cd-U. B2-MG and RBP
n urine are fairly sensitive markers of tubular dysfunction. B2-MG
s, however, less stable in acid urine than RBP. Referring to Bernard
t al. (1995), RBP in urine is useful in screening for early tubular dys-
unction induced by Cd. However, a few recent studies underline
hat the associations between low concentrations of Cd and LMW
roteins in urine, might be non-causal and should merely be driven
y factors such as diuresis, protein-metal coexcretion and chronic
moking (Akerstrom et al., 2013; Bernard, 2008; Chaumont et al.,
012; Haddam et al., 2011). Akerstrom et al. (2013) noted that the
ssociation between low Cd-U and LMW  proteins appear unlikely
o be caused by Cd but are partly a result of normal variation in
enal function that inﬂuence the excretion of Cd and LMW  proteins
n urine in the same direction. The authors emphasize that this can
ead to overestimate the adverse effects of Cd at low concentra-
ions (Akerstrom et al., 2013). Chaumont and coworkers suggested
hat two mechanisms can cause protein-metal coexcretion. The
rst mechanism is the physiological variation in the uptake of pro-
eins by the PT. The authors mentioned that B2-MG is probably
eabsorbed earlier along the PT than RBP or Cd-MT complex. The
econd mechanism is a competitive inhibition of the reabsorption
f LMW protein by increased albumin. This mechanism is probably
inked to a receptor-mediated endocytosis of proteins (i.e., albu-
in, RPB, B2-MG and MT)  that takes place in the PT (Chaumont
t al., 2012). It is known that smoking is a major source of cad-
ium exposure. However, the possibility of confounding through
 non-cadmium-dependent effect of smoking on the kidney must
lso be considered. The exact mechanism by which smoking can
ause renal damage is unknown (Bernhard et al., 2005; Hambach
t al., 2013b; McNamee, 2003; Mercado and Jaimes, 2007; Orth
t al., 2001). One mechanism might be that smoking would make
he kidney more sensitive to Cd toxicity (Chaumont et al., 2011).
e considered the presence of modiﬁcation for smoking by includ-
ng a second interaction term in the model and the associations
emained robust. Our results showed only modiﬁcation on the asso-
iation between Cd-U and NAG. After removal of all ‘ever smokers’,
he interactions Pb-B × Cd-B and Pb-B × Cd-U remained statistically
igniﬁcant, indicating that the impact of Cd-B on the urinary excre-
ion of NAG and IAP and Cd-U on NAG and RBP was  only evident
mong workers with Pb-B ≥ 219.3 g/l.
Urinary enzymes such as IAP and NAG are elevated because of
he release from the damaged tubular cells or from regenerating
ells in which enzyme induction is intensiﬁed (D’Amico and
azzi, 2003). IAP, a brush border enzyme of the S3 segment of the
roximal tubule, has been identiﬁed as a sensitive indicator of Cd
nduced renal damage, as well (Hambach et al., 2013a; Kido et al.,
995; Taylor et al., 1997). NAG is a high molecular weight lysosomal
nzyme that is found in many tissue of the body and cannot pass
hrough glomerular ultraﬁltration (Kalahasthi et al., 2007; Kavukc¸ u
t al., 2002). The urinary activity of total NAG is the sum of activities
f several isoenzymes (Brzóska et al., 2004). The isoenzymes A
NAG-A) and B (NAG-B) are the main isoenzymes found in human
idneys. NAG-A is a part of the intralysosomal compartment and
xcreted in urine via exocytosis. NAG-B is linked to the lysosomal
embrane and excreted in urine during tubular damage (Chia
t al., 1994; Jin et al., 1999; Kalahasthi et al., 2007). Total NAG
s one of the most studied and best characterized biomarker of
enal toxicity (Brzóska et al., 2004; Ferguson et al., 2008). Several
tudies described increased NAG concentrations at relatively low
d-U (<2 g/g creatinine) (Fowler, 2009; Hambach et al., 2013a;
eaver et al., 2010). According to Roels et al. (1995), the observedssociation between NAG and moderately high exposure to Pb-B,
s seen in previous studies, can be explained by the fact that several
uthors did not take into account the effect of concomitant low Cd
xposure.tters 222 (2013) 233– 238 237
To our knowledge, occupational studies examining the adverse
effects of concomitant exposure to Cd and Pb in humans are limited
(Buchet et al., 1981; Garc¸ on et al., 2004, 2007; Cárdenas et al., 1993,
Roels et al., 1994) and to the best of our knowledge no studies have
been performed on Pb and Cd concentrations as low as those of
the present study. Another strength of the study is that we used a
rather complete battery of biomarkers for screening early tubular or
glomerular dysfunction. A relative limitation of this research is the
cross-sectional design of this study which provides no information
on the temporal sequence between exposure and outcome. Fur-
thermore, Garc¸ on et al. (2007) mentioned that the surveillance of
nephrotoxicity induced by occupational Cd and Pb exposure relies
on the ability to detect renal effects at a stage when they are still
reversible. However, there is still some debate as to whether the
induced tubular effects are reversible or not (Mason et al., 1999;
Garc¸ on et al., 2007; Thomas et al., 2009). In conclusion, relatively
low Cd-B and Cd-U levels were found in the participating work-
ers from a metallurgic reﬁnery company whereas Pb exposure was
moderately high. Our ﬁndings indicate that Pb modiﬁes (increases)
the strength of the association between Cd (in blood and urine) and
early renal biomarkers of dysfunction (i.e., NAG/IAP/RBP).
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